Abstract
This mini review aims to outline some of the non testing approaches that are available for the purposes of predicting and assuring drug safety. Focus will be made on several endpoints of specific concern such as ADME properties as well as mutagenicity and carcinogenicity. The use of TTC and chemical categories approaches are presented as alternative strategies. Overall there is great potential to apply a battery of different tools in drug discovery from QSARs to TTC and chemical categories. Greater awareness of other initiatives (in parallel industries) coupled with more practical guidance on how to exploit these tools is still required before they become embedded into routine use.
Keywords: Quantitative structure activity relationships, expert systems, ADME, mutagenicity, carcinogenicity, thresholds of, toxicological concern (TTC), chemical categories
Current Computer-Aided Drug Design
Title: Computational Methods to Predict Drug Safety
Volume: 2 Issue: 2
Author(s): Grace Patlewicz
Affiliation:
Keywords: Quantitative structure activity relationships, expert systems, ADME, mutagenicity, carcinogenicity, thresholds of, toxicological concern (TTC), chemical categories
Abstract: This mini review aims to outline some of the non testing approaches that are available for the purposes of predicting and assuring drug safety. Focus will be made on several endpoints of specific concern such as ADME properties as well as mutagenicity and carcinogenicity. The use of TTC and chemical categories approaches are presented as alternative strategies. Overall there is great potential to apply a battery of different tools in drug discovery from QSARs to TTC and chemical categories. Greater awareness of other initiatives (in parallel industries) coupled with more practical guidance on how to exploit these tools is still required before they become embedded into routine use.
Export Options
About this article
Cite this article as:
Patlewicz Grace, Computational Methods to Predict Drug Safety, Current Computer-Aided Drug Design 2006; 2 (2) . https://dx.doi.org/10.2174/157340906777441735
DOI https://dx.doi.org/10.2174/157340906777441735 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ghrelin in Hypothalamic Regulation of Energy Balance
Current Topics in Medicinal Chemistry Destroying RNA as a Therapeutic Approach
Current Medicinal Chemistry Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
Current Pharmaceutical Design Possible Targets of Herbals for Type 3 Diabetes: A Review
Current Traditional Medicine Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Mini-Reviews in Medicinal Chemistry Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Current Status of Newer Carbapenems
Current Medicinal Chemistry Behcets Syndrome: Literature Review
Current Rheumatology Reviews Understanding Genetic Factors in Idiopathic Scoliosis, a Complex Disease of Childhood
Current Genomics Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Recent Developments on the Synthesis of Biologically Significant bis/tris(indolyl)methanes under Various Reaction Conditions: A Review
Current Organic Chemistry Phytoconstituents of <i>Lantana camara</i> L.: Rekindling Hope in the Cancer Treatment
Current Bioactive Compounds Global View on Rare Diseases: A Mini Review
Current Medicinal Chemistry Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism Editorial (Hot Topic: Neurodegeneration: The First IBRO-Middle East Neuroscience Conference)
Current Alzheimer Research Advanced Neoplastic Disease as Immunologic, Endocrine and Metabolic Disorder
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Biological Responses to Hydrogen Molecule and its Preventive Effects on Inflammatory Diseases
Current Pharmaceutical Design Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine Targeting Molecular Imaging Approach for Detection of Infection and Inflammation by Diagnostic Nuclear Medicine Techniques
Current Medical Imaging